<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02888275</url>
  </required_header>
  <id_info>
    <org_study_id>H1608-052-784</org_study_id>
    <nct_id>NCT02888275</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine in Pediatric Cardiac Surgery</brief_title>
  <official_title>The Renal Protective Effect of the Dexmedetomidine in Pediatric Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      Dexmedetomidine is a selective Î±-2 receptor agonist with a sedative and cardiopulmonary
      profile that makes it an attractive anesthetic for pediatric patients with congenital heart
      disease (CHD). The aim of this study was to investigate the renal protective effect of
      dexmedetomidine in the perioperative setting in children with heart disease.

      Total 144 pediatric patients allocated dexmedetomidine (DEX) and did not receive the drug
      (NoDEX) group.

      The primary objective of this study was to assess the relationship between the use of
      intraoperative dexmedetomidine and the incidence of acute kidney injury in pediatric patients
      undergoing cardiopulmonary bypass. The secondary objective was to determine whether there was
      an association between dexmedetomidine use and duration of mechanical ventilation or
      cardiovascular ICU stay.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum creatinine</measure>
    <time_frame>immediate after surgery, until discharge from the ICU, assessed up to 1 week.</time_frame>
    <description>daily check the laboratory parameter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>glomerular filtration rate</measure>
    <time_frame>immediate after surgery, until discharge from the ICU, assessed up to 1 week.</time_frame>
    <description>daily check the laboratory parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine output</measure>
    <time_frame>immediate after surgery, until discharge from the ICU, assessed up to 1 week.</time_frame>
    <description>daily check the laboratory parameter.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>DEX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine 1mcg/kg for 10min. loading and continuous infusion during the surgery 0.5mcg/kg/hr.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no_DEX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal saline 1mcg/kg for 10min. and continuous infusion during the surgery 0.5mcg/kg/hr.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>DEX</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <arm_group_label>no_DEX</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing congenital cardiac surgery for the correction of the atrial septal
             defect or ventricular septal defect

        Exclusion Criteria:

          -  history of allergy or anaphylaxis to study drug

          -  preexisting renal dysfunction (preoperative creatinine &gt;1.5mg/dl)

          -  diabetes

          -  liver profile abnormality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin-Tae kim, professor</last_name>
    <phone>82-2-2072-3664</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jin-Tae Kim</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, MD. PhD</last_name>
      <phone>82-2-2072-3295</phone>
      <email>kimjintae73@dreamwiz.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

